Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:57:55.438Z.
Calculation as of: 2026-10-06T18:57:55.438Z.
Quote observation: 2026-10-06T18:55:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bddae1a009f0b40e7fb659cb125a310776fd64778f9839bff19075a224db575c
EARNINGS YIELD
N/A
Market Cap
$169.85M
Earnings Yield
N/A
TTM Avg
4.56%
3Y Avg
2.71%
5Y Avg
6.34%
Market Cap
$171.26M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
Market Cap
$173.52M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $168.49M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.99M | N/A | 15.95% | 15.95% | 15.95% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | 4.56% | 2.71% | 6.34% |
| Cue Biopharma, Inc. (CUE)vs › | $170.21M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.26M | N/A | 12.15% | 12.15% | 12.15% |
| OptimizeRx Corp. (OPRX)vs › | $165.70M | 2.65% | 4.73% | 4.73% | 1.51% |
| Quanterix Corporation (QTRX)vs › | $164.40M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $173.52M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | N/A | 18.91% | 18.91% | 12.56% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
